Geovax Labs Inc (GOVX)
3.31
+0.03
(+0.91%)
USD |
NASDAQ |
Jul 02, 16:00
3.19
-0.12
(-3.63%)
Pre-Market: 08:22
Geovax Labs Free Cash Flow: -27.09M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -27.09M |
| December 31, 2023 | -25.22M |
| September 30, 2023 | -21.99M |
| June 30, 2023 | -20.74M |
| March 31, 2023 | -18.53M |
| December 31, 2022 | -19.16M |
| September 30, 2022 | -18.78M |
| June 30, 2022 | -16.59M |
| March 31, 2022 | -14.02M |
| December 31, 2021 | -11.24M |
| September 30, 2021 | -6.257M |
| June 30, 2021 | -4.881M |
| March 31, 2021 | -4.170M |
| December 31, 2020 | -2.907M |
| September 30, 2020 | -1.495M |
| June 30, 2020 | -1.554M |
| March 31, 2020 | -1.443M |
| December 31, 2019 | -1.406M |
| September 30, 2019 | -1.624M |
| June 30, 2019 | -1.559M |
| March 31, 2019 | -1.483M |
| December 31, 2018 | -1.543M |
| September 30, 2018 | -1.490M |
| June 30, 2018 | -1.689M |
| March 31, 2018 | -1.738M |
| Date | Value |
|---|---|
| December 31, 2017 | -1.693M |
| September 30, 2017 | -1.613M |
| June 30, 2017 | -1.537M |
| March 31, 2017 | -1.654M |
| December 31, 2016 | -1.946M |
| September 30, 2016 | -2.338M |
| June 30, 2016 | -2.590M |
| March 31, 2016 | -2.715M |
| December 31, 2015 | -2.721M |
| September 30, 2015 | -2.594M |
| June 30, 2015 | -2.449M |
| March 31, 2015 | -2.417M |
| December 31, 2014 | -2.286M |
| September 30, 2014 | -2.474M |
| June 30, 2014 | -2.125M |
| March 31, 2014 | -1.940M |
| December 31, 2013 | -1.781M |
| September 30, 2013 | -1.506M |
| June 30, 2013 | -1.579M |
| March 31, 2013 | -1.549M |
| December 31, 2012 | -2.441M |
| September 30, 2012 | -1.684M |
| June 30, 2012 | -1.553M |
| March 31, 2012 | -1.003M |
| December 31, 2011 | -0.3036M |
Free Cash Flow Range, Past 5 Years
-27.09M
Minimum
Mar 2024
-1.406M
Maximum
Dec 2019
-11.53M
Average
-11.24M
Median
Dec 2021
Free Cash Flow Benchmarks
| Merck & Co Inc | 11.04B |
| Pfizer Inc | 5.106B |
| Processa Pharmaceuticals Inc | -7.998M |
| Biomea Fusion Inc | -105.08M |
| Moderna Inc | -3.672B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -5.684M |
| Free Cash Flow Per Share (Quarterly) | -2.401 |
| Free Cash Flow Yield | -415.5% |